"Votrient - API Insight, 2020" report provides product and API manufacturers details across US, Europe, China and India for Votrient . It includes Votrient overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Votrient’s patents information (US & EU). It also features the historical and forecasted sales of Votrient till 2022. The report also highlights Votrient’s market competition and emerging therapies which are in the same space as Votrient
Methodology Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis ’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.
Scope of the report A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
Patent information around Votrient in United States (US) and Europe (EU) has been highlighted
API manufacturers for Votrient in United States, Europe, China and India
The report contains historical and forecasted sales for Votrient till 2022
Enlists the market competition and emerging therapies in the space where Votrient operates
Reasons to Buy Establish a comprehensive understanding of the drug, Votrient
Access to Votrient’s API manufacturers details to devise API procurement strategy for generic development
Plan generic developmental timelines around Votrient’s patents for the major markets- US and EU
Understand Votrient’s current and future growth through its historical and forecasted sales
Identify the current in-market competitors for Votrient
Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
Identify the emerging players and their products operating in the same space as Votrient.
Our reports have been used by over 10K customers, including:
The global eClinical Solutions market is projected to reach USD 15.4 billion by 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%. Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and growing R&D expenditure on drug development by pharma-biotech...
The ePRO, ePatient Diaries, and eCOA market in Europe is expected to grow from US$ 447.8 million in 2021 to US$ 1,184.3 million by 2028; it is estimated to grow at a CAGR of 14.9% from 2021 to 2028. As per the data provided by Clinicaltrials.gov, 2016 has been a big one for clinical research. There were around 366 thousand clinical studies...
The analyst presents post–COVID-19 growth opportunities and strategic imperatives for the global decentralized clinical trials (DCT) market, covering the market’s maturity, key participants, adoption drivers and restraints, and recent mergers and acquisitions. The report identifies initiatives by major global contract research organizations...
The ePRO, epatient diaries, and eCOA market was valued at US$ 1,342.92 million in 2020 and it is projected to reach US$ 4,130.35 million by 2028; it is expected to grow at a CAGR of 15.08% during 2020-2028. Increasing demand for electronic health records (EHRs) and rising use of smartphones are fueling the market growth. However, concerns...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline (GSK), Novartis AG, and Novo Nordisk A/S. The global biosimilar therapeutic peptides market is expected to grow from $0.76 billion in 2020 to $0.87...
The ePRO, ePatient diaries, and eCOA market in Asia Pacific is expected to grow from US$ 348.8 million in 2021 to US$ 964.2 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2021 to 2028. Healthcare systems are experiencing a rise in consumer engagement worldwide. In developing countries, health care systems are becoming more...
The ePRO, ePatient Diaries, and eCOA market in Middle East and Africa is expected to grow from US$ 48.4 million in 2021 to US$ 112.3 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028. Increasing number of smartphone users is likely to boost the ePRO, e-Patient Diaries, and eCOA’s adoption in the coming years. Mobile-enabled...
The ePRO, ePatient Diaries, and eCOA market in North America is expected to grow from US$ 607.2 million in 2021 to US$ 1,640.6 million by 2028; it is estimated to grow at a CAGR of 15.3% from 2021 to 2028. Increasing number of smartphone users is likely to boost the ePRO, e-Patient Diaries, and eCOA’s adoption in the coming years. As per the...
The ePRO, ePatient Diaries, and eCOA market in South and Central America is expected to grow from US$ 90.3 million in 2021 to US$ 229.0 million by 2028; it is estimated to grow at a CAGR of 14.2% from 2021 to 2028. Patient centricity means designing a treatment, clinical trial, or other health solution centered around the patient. Creating...
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Data Management), By Region, And Segment Forecasts, 2021 - 2028 Healthcare Contract Research Organization Market Growth & Trends The...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.